Sophisticated Antibody Analysis by GPC/SEC with RALS
PSS Polymer Standards Service GmbH
Monoclonal antibodies (mABs) are increasingly growing in importance for the diagnosis and therapy of various diseases, including cancer and autoimmune and inflammatory disorders. One essential parameter to define their quality is the content of aggregates (dimers, trimers, and higher aggregates). These aggregates can be formed during processing and purification or are the result of long-term storage. As a result of aggregation, antibodies lose their pharmaceutical efficacy and can facilitate an immunology response.
Antibody fragments which lack the Fc region can be used for the treatment of diseases. They can also be the result of degradation of full length antibodies. Therefore, a GPC method, which offers the opportunity to analyse antibodies and their aggregates, as well as antibody fragments simultaneously, with superior resolution and high sensitivity is invaluable.
Experimental
GPC/SEC analysis was performed on a PSS SECcurity GPC system, equipped with a PSS SECcurity SLD1000 light scattering detector, using the following conditions:
Results
Figure 1 shows an overlay of elugrams obtained for a full length antibody and antibody fragments analysed on a single set of columns.
Figure 1: Separation range of the column combination. The red curve shows the UV signal of a full length antibody and its dimers plotted against the elution volume. The blue curve is the elugram of antibody fragments and their high level aggregates.
All three detector signals for the analysis of a monoclonal antibody are shown in Figure 2. The light scattering signal shows improved sensitivity for high aggregates compared to the other signals.
Figure 2: Sensitive analysis of antibody aggregates. The light scattering signal for the dimer is relatively high compared to that of the mABs because of molar mass dependency and provides improved sensitivity for the detection of high aggregates (inset).
Conclusion
The GPC/SEC method including UV, RI, and RALS can be used for the simultaneous determination of aggregate content of monoclonal antibodies as well as antibody fragments. The column combination covers the separation range for all three types and provides a high resolution for the determination of the dimer content. Because of its molecular weight dependency, the PSS SLD1000 RALS detector offers high sensitivity for very small quantities of high aggregates and also allows the determination of the absolute molecular weight of the antibodies. In addition, it has a unique feature for a light scattering detector as the wavelength can be altered to increase the sensitivity.
PSS Polymer Standards Service GmbH
In der Dalheimer Wiese 5, D-55120 Mainz, Germany
Tel: + 49 6131 962390 fax: + 49 6131 962390 11
E-mail: info@pss-polymer.com
Website: www.pss-polymer.com
Free Poster: NDSRI Risk Assessment and Trace-Level Analysis of N-Nitrosamines
April 25th 2025With increasing concern over genotoxic nitrosamine contaminants, regulatory bodies like the FDA and EMA have introduced strict guidelines following several high-profile drug recalls. This poster showcases a case study where LGC and Waters developed a UPLC/MS/MS method for quantifying trace levels of N-nitroso-sertraline in sertraline using Waters mass spectrometry and LGC reference standards.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
Using the Carcinogenic Potency Categorisation Approach (CPCA) to Classify N-nitrosamine Impurities
April 25th 2025Learn how to manage nitrosamine impurities in pharmaceuticals with our free infographic. Discover how the CPCA approach establishes acceptable intake limits and guides the selection of NDSRI reference samples. Stay compliant and ensure safety with our ISO-accredited standards.
